Access the updated page using the API Locator.   Our Custom Search for Pharma News…

FDA Approval Activities for this Drug… NALIDIXIC ACID Tablet; 1GM NEGGRAM SANOFI SYNTHELABO | 014214 NALIDIXIC ACID Tablet; 250MG NEGGRAM SANOFI SYNTHELABO | 014214 NALIDIXIC ACID Tablet; 500MG NEGGRAM SANOFI SYNTHELABO | 071919 NALIDIXIC ACID Tablet; 1GM NALIDIXIC ACID Watson | 071936 NALIDIXIC ACID Tablet; 250MG NALIDIXIC ACID Watson | 072061 NALIDIXIC ACID Tablet; 500MG NALIDIXIC ACID Watson NegGram (nalidixic acid) Caplets, Sanofi-Synthelabo, Labeling Revision NegGram (nalidixic acid) Suspension, Sanofi-Synthelabo, Labeling Revision | NegGram (nalidixic acid) Caplets, Sanofi-Aventis, Labeling Revision | NegGram (nalidixic acid) Oral Suspension, Sanofi-Aventis, Labeling Revision | NegGram (nalidixic acid) Tablets, Sanofi Aventis U.S. LLC, Labeling Revision | NegGram (nalidixic acid) Caplets, Sanofi-aventis U.S. Inc., Labeling Revision View updates.                                                                       A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News | VOIP © 2012 Betterchem.com